Schedule 13D ownership disclosure

ENTASIS THERAPEUTICS HLDGS I

Security class unavailable · CUSIP: 293614103

Event date: 2020-03-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-082433
Form type
SC 13D/A
Filer
Entasis Therapeutics Holdings Inc.
CIK
CIK 1724344
Filed
Mar 23, 2020
Reporting period
Mar 19, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub